| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Rudolf Virchow Center (S.M., M.P.S., M.B., R.J.A.F., S.E.), Deutsche Forschungsgemeinschaft-Research Center for Experimental Biomedicine; Department of Internal Medicine (S.F., J.B.); Department of Dermatology, Venereology and Allergology (M.P.S.); and Institute of Pharmacology and Toxicology (E.S., M.J.L.), University of Wuerzburg, Germany.
Correspondence to Stefan Engelhardt, MD PhD, Rudolf Virchow Center, DFG-Research Center for Experimental Biomedicine, University of Wuerzburg, Versbacher Strasse 9, 97078 Wuerzburg, Germany. E-mail stefan.engelhardt{at}virchow.uni-wuerzburg.de
Apoptosis of cardiomyocytes is increased in heart failure and has been implicated in disease progression. The activation of "proapoptotic" caspases represents a key step in cardiomyocyte apoptosis. In contrast, the role of "proinflammatory" caspases (caspases 1, 4, 5, 11, 12) is unclear. Here, we study the cardiac function of caspase-1. Gene array analysis in a murine heart failure model showed upregulation of myocardial caspase-1. In addition, we found increased expression of caspase-1 protein in murine and human heart failure. Mice with cardiomyocyte-specific overexpression of caspase-1 developed heart failure in the absence of detectable formation of interleukin (IL)-1ß or IL-18 and inflammation. Transgenic caspase-1 induced primary cardiomyocyte apoptosis before structural and molecular signs of myocardial remodeling occurred. In contrast, deletion of endogenous caspase-1 was beneficial in the setting of myocardial infarctioninduced heart failure. Furthermore, caspase-1deficient mice were protected from ischemia/reperfusion-induced cardiomyocyte apoptosis. Studies in primary rat cardiomyocytes indicated that caspase-1 induces cardiomyocyte apoptosis primarily through activation of caspases-3 and -9. In contrast to previous findings, which imply a proinflammatory role of caspase-1, these data suggest a primary proapoptotic role for caspase-1 in cardiomyocytes. Our findings support a functional role for caspase-1mediated myocardial apoptosis contributing to the progression of heart failure.
Key Words: caspase-1 transgenic mouse heart failure
This article has been cited by other articles:
![]() |
E. J. Birks, N. Latif, K. Enesa, T. Folkvang, L. A. Luong, P. Sarathchandra, M. Khan, H. Ovaa, C. M. Terracciano, P. J.R. Barton, et al. Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy Cardiovasc Res, August 1, 2008; 79(3): 472 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abbate, F. N. Salloum, E. Vecile, A. Das, N. N. Hoke, S. Straino, G. G.L. Biondi-Zoccai, J.-E. Houser, I. Z. Qureshi, E. D. Ownby, et al. Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction Circulation, May 20, 2008; 117(20): 2670 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J.A. Frost and S. Engelhardt A Secretion Trap Screen in Yeast Identifies Protease Inhibitor 16 as a Novel Antihypertrophic Protein Secreted From the Heart Circulation, October 16, 2007; 116(16): 1768 - 1775. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |